Effect of Lifitegrast 5% on Tear Film Markers

Withdrawn before enrolling · Phase 4

Conditions studied: Dry Eye, Dry Eye Syndromes, Dry Eyes Chronic

In brief

The purpose of this study is to assess the duration of time (in weeks) for improvement in objective dry eye markers for people who are placed on lifitegrast 0.5% (Xiidra®), an FDA-approved therapy for dry eyes.

Key facts

Study ID
NCT03952481
Run by
Weill Medical College of Cornell University
People needed
0
Starts
2021-03-01
Expected to finish
2021-12-31
Last updated by the study team
2021-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.